The heel incision device provides a safe and efficient means for acquiring blood samples from the heels of newborns. Sterile, single-use and not made with natural rubber latex. It utilizes an automated lancing mechanism that delivers a smooth incision with less trauma to the heel.

Market Analysis and Insights: Global Heel Incision Devices Market
The global Heel Incision Devices market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Heel Incision Devices Scope and Market Size
The global Heel Incision Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heel Incision Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Micro-preemie
Preemie
Newborn
Infant

Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

The Heel Incision Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Heel Incision Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Owen Mumford Ltd.
Cardinal Health
NSP Medicals
Torvan Medical Inc
Smiths Medical
Clinical Innovations
LLC
MediCore
Vitrex Medical A/S